These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17262024)

  • 1. Fanconi anemia and breast cancer susceptibility.
    Patel KJ
    Nat Genet; 2007 Feb; 39(2):142-3. PubMed ID: 17262024
    [No Abstract]   [Full Text] [Related]  

  • 2. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
    Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
    Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. D-Day for BRCA2.
    Witt E; Ashworth A
    Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
    Lakhi NA; Mizejewski GJ
    Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New complexities for BRCA1 and BRCA2.
    Kerr P; Ashworth A
    Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility pathways in Fanconi's anemia and breast cancer.
    D'Andrea AD
    N Engl J Med; 2010 May; 362(20):1909-19. PubMed ID: 20484397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited.
    Howlett NG
    Eur J Hum Genet; 2007 Jul; 15(7):715-7. PubMed ID: 17505525
    [No Abstract]   [Full Text] [Related]  

  • 10. A growing network of cancer-susceptibility genes.
    Venkitaraman AR
    N Engl J Med; 2003 May; 348(19):1917-9. PubMed ID: 12736286
    [No Abstract]   [Full Text] [Related]  

  • 11. Ten genes for inherited breast cancer.
    Walsh T; King MC
    Cancer Cell; 2007 Feb; 11(2):103-5. PubMed ID: 17292821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
    Wang W
    Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in understanding molecular pathogenesis of Fanconi anemia].
    Yamashita T; Oda T; Sekimoto T
    Rinsho Ketsueki; 2009 Jul; 50(7):538-46. PubMed ID: 19638721
    [No Abstract]   [Full Text] [Related]  

  • 15. The two faces of BRCA2, a FANCtastic discovery.
    Stewart G; Elledge SJ
    Mol Cell; 2002 Jul; 10(1):2-4. PubMed ID: 12150898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fanconi anemia and DNA-damage response network].
    Matsushita N; Kitao H; Ishiai M; Takata M
    Tanpakushitsu Kakusan Koso; 2009 Mar; 54(4 Suppl):580-5. PubMed ID: 21089513
    [No Abstract]   [Full Text] [Related]  

  • 18. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
    Rahman N; Seal S; Thompson D; Kelly P; Renwick A; Elliott A; Reid S; Spanova K; Barfoot R; Chagtai T; Jayatilake H; McGuffog L; Hanks S; Evans DG; Eccles D; ; Easton DF; Stratton MR
    Nat Genet; 2007 Feb; 39(2):165-7. PubMed ID: 17200668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and disease-associated genetic variation in the human Fanconi anemia gene family.
    Rogers KJ; Fu W; Akey JM; Monnat RJ
    Hum Mol Genet; 2014 Dec; 23(25):6815-25. PubMed ID: 25104853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PALB2/FANCN: recombining cancer and Fanconi anemia.
    Tischkowitz M; Xia B
    Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.